NCT07193290

Brief Summary

This is a randomized, decentralized, non-interventional clinical study. The primary objective of this study is to develop execution and efficiency metrics from completion of this study to inform on the potential design for future projects. The secondary objective of this study is to assess the main study endpoints across balanced attributes of study sub-populations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,027

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 13, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 25, 2025

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

5 months

First QC Date

July 21, 2025

Last Update Submit

December 12, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Interaction efficiency (contacted vs. enrolled)

    The number and percentage of subjects who interacted with the digital study activities vs number and percentage of subjects who completed the study.

    4 weeks post Last Subject's remote visit

  • Percent completion of subject self-taken images

    The number and percentage of subjects who successfully completed the self-taken images.

    4 weeks post Last Subject's remote visit

  • Percent completion of subjects participating in bio-sampling subset

    The number and percentage of subjects who successfully completed the bio-sampling procedures.

    4 weeks post Last Subject's remote visit

Secondary Outcomes (2)

  • Questionnaire results compared across skin tone

    4 weeks post Last Subject's remote visit

  • Questionnaire results compared across age groups

    4 weeks post Last Subject's remote visit

Study Arms (2)

Non-Skin Microbiome Subset

18- to 65-year-old female subjects.

Other: Lifestyle QuestionnaireOther: Self-portrait image (Face and Hair)

Skin Microbiome Subset

18- to 65-year-old female subjects randomly assigned in the skin microbiome subset

Other: Lifestyle QuestionnaireOther: Self-portrait image (Face and Hair)Diagnostic Test: Skin microbiome collection

Interventions

All subjects will take one self-portrait image of their face and hair

Non-Skin Microbiome SubsetSkin Microbiome Subset

Subjects randomly assigned in the skin microbiome subset will complete the skin microbiome collection

Skin Microbiome Subset

All subjects will complete the lifestyle questionnaire

Non-Skin Microbiome SubsetSkin Microbiome Subset

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The target population is 18- to 65-year-old, healthy female subjects.

You may qualify if:

  • Self-reported Monk skin type 1 to 10, targeting to complete at least 100 subjects for each Monk skin type.
  • to 65 years old, targeting to complete:
  • to 40-year-old age range: at least 50 subjects within each Monk type
  • to 65-year-old age range: at least 50 subjects within each Monk type
  • Lives within an Inner City, Urban, Suburban, or Rural community type (as determined by self-report or provided zip code), targeting to complete:
  • Inner City/Urban community type: at least 25 subjects within each age range and Monk type
  • Suburban/Rural community type: at least 25 subjects within each age range and Monk type
  • Has electronically accepted the Consent for Photograph Release and ICD including Health Insurance Portability and Accountability Act (HIPAA) disclosure.
  • Has a personal smartphone with a camera and an internet connection (wi-fi, cellular services, etc.).
  • Intends to complete the study and willing and able to follow all study instructions.

You may not qualify if:

  • Has known allergies or adverse reactions to topical adhesives.
  • Is simultaneously participating in any other clinical study for the duration of this study or has participated in any product-use study within 30 days prior to remote Visit 1.
  • Is an employee/contractor or immediate family member of the PI, study technology provider, laboratory, or Sponsor.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laina Enterprises, Inc.

Apopka, Florida, 32712, United States

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2025

First Posted

September 25, 2025

Study Start

May 13, 2025

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

December 19, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations